Internal Medicine, Infectious Disease · Columbus, OH
NPI
1265657134
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1581 Dodd Dr
Columbus, OH, 43210
Phone (614) 293-4854
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
448 services
Medicare patients, 2024
199
Average age 71
Drug cost, 2024
$881K
489 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christina T Liscynesky was code 99232 (hospital e&m - subsequent), 176 times for 85 patients. In total Christina T Liscynesky billed 448 services in 22 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 176 | 85 | $57.85 | $10K |
| 99223 Hospital E&M - Initial | Facility | 65 | 65 | $130.84 | $8,505 |
| 99233 Hospital E&M - Subsequent | Facility | 53 | 37 | $89.69 | $4,754 |
| 99222 Hospital E&M - Initial | Facility | 46 | 45 | $98.35 | $4,524 |
| 99214 Office E&M - Established | Office | 19 | 16 | $86.29 | $1,639 |
| 99213 Office E&M - Established | Office | 12 | 12 | $62.37 | $748 |
By year: 2022 $25K for 278 services; 2023 $28K for 326 services; 2024 $36K for 448 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christina T Liscynesky prescribed most often to Medicare patients was Triumeq (Abacavir/Dolutegravir/Lamivudi), with 36 prescriptions and refills. In total Christina T Liscynesky wrote 489 Medicare prescriptions that cost $881K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triumeq Abacavir/Dolutegravir/Lamivudi | 36 | 36 | Under 11 | $129K |
| Amikacin Sulfate Generic | 33 | 33 | Under 11 | $2,355 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 30 | 30 | Under 11 | $25K |
| Azithromycin Generic | 28 | 38 | Under 11 | $640 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 26 | 26 | Under 11 | $100K |
| Ethambutol Hcl Generic | 26 | 34 | Under 11 | $1,637 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 25 | Under 11 | $471 |
| Entecavir Generic | 21 | 21 | Under 11 | $3,177 |
| Penicillin V Potassium Generic | 21 | 21 | Under 11 | $271 |
| Doxycycline Hyclate Generic | 17 | 17 | Under 11 | $140 |
| Descovy Emtricitabine/Tenofov Alafenam | 15 | 15 | Under 11 | $32K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 14 | 14 | Under 11 | $54K |
| Amoxicillin Generic | 14 | 14 | Under 11 | $107 |
| Cephalexin Generic | 13 | 13 | Under 11 | $138 |
| Tivicay Dolutegravir Sodium | 13 | 13 | Under 11 | $55K |
Brand drugs: 187 claims; generic drugs: 302 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Christina T Liscynesky were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.